Comparison Overview
Roche Diagnostics USA
Roche Diagnostics USA
9115 Hague Rd, Indianapolis, 46256, US
Last Update: 19/04/2026
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche Diagnostics is the world leader in in-vitro diagnostics. Working at Roche mean...
Syneos Health
1030 Sync Street, Morrisville, 27560, US
Last Update: 01/04/2026
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a ta...
Compliance Ranges Comparison
Roche Diagnostics USA
Syneos Health
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Roche Diagnostics USA in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Syneos Health in 2026.
Incident History - Roche Diagnostics USA (X = Date, Y = Severity)
Roche Diagnostics USA cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Syneos Health (X = Date, Y = Severity)
Syneos Health cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Roche Diagnostics USA
Syneos Health
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.